| Bid | Ask | |
| Price | n.a. | n.a. |
| Volume | n.a. | n.a. |
| Change compared with previous day | n.a. | n.a. |
| Time | n.a. | n.a. |
| Date | n.a. | n.a. |
| Currency | ||
| Nominal amount | ||
| Exchange | ||
| Life cycle | redeemed | |
| Daily high/low | n.a. / n.a. |
| All-time high/low | n.a. / n.a. |
| Performance of structured product since issue | |
| Performance of underlying since issue | n.a. |
| Risk | |
| SSPA VaR | |
| SSPA risk rating |
| Volatility | |
| 30-day volatility | |
| 100-day volatility |
| Investment style | |
| Participation |
| ZKB Reverse Convertible auf Novo Nordisk A/S 140250665 / CH1402506658 |
| ZKB Barrier Reverse Convertible mit bedingtem Coupon, 24.06.2027 on worst of NVO UN/ROG SE/TEVA UN 144651781 / CH1446517810 |
| ZKB Barrier Reverse Convertible auf Novo Nordisk A/S 144652645 / CH1446526456 |
| ZKB Autocallable Barrier Reverse Convertible on worst of BASF SE/Novo Nordisk A/S/Vale SA 144652631 / CH1446526316 |
| ZKB Callable Barrier Reverse Convertible on worst of ASML Holding NV/Moët Hennessy Louis Vuitton SE/... 142530512 / CH1425305120 |